BCL2 and colorectal carcinoma: Downregulated BCL2 could suppress F. nucleatum induced chemoresistance (Figures 4b, c) and block the inhibition of LDH release by F. nucleatum in patient tissue-derived CRC organoids as well (Figure 4d).